Alibaba Health Information Technology Ltd

Common Name
Alibaba Health
Country
Hong Kong
Sector
Healthcare
Industry
Pharmaceutical Retailers
Employees
1,364
Ticker
241
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services busine...

Financial Statements of Alibaba Health

Below are the financial statements of Alibaba Health, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of CNY20242023
Revenue
27,026.56a
26,763.02a
Cost of sales
-21,131.23a
-21,061.68a
Gross profit
5,895.32a
5,701.33a
Other income and gains
674.76a
618.07a
Operating expenses
Fulfilment
-2,413.21a
-2,907.14a
Selling and marketing expenses
-1,776.56a
-1,768.68a
Administrative expenses
-359.98a
-379.49a
Product development expenses
-705.38a
-677.82a
Other expenses and losses
-363.64a
-40.84a
Finance costs
-5.97a
-5.83a
Share of profits/(losses) of
Joint ventures
1.04a
48.98a
Associates
-6.97a
-37.6a
Profit before tax
939.4a
550.99a
Income tax expense
-56.26a
-14.49a
Profit for the year
883.14a
536.51a
Attributable to
Owners of the parent
883.48a
535.65a
Non-controlling interests
-0.34a
0.86a
Download Data

Verified Sources Behind Alibaba Health’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Alibaba Health’s data sources below and access millions more through our Disclosure Search.

a. Alibaba Health's Annual Report 2024
a. Alibaba Health's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?